Abassi ZA et al (1993) Metabolism of endothelin-1 and big endothelin-1 by recombinant neutral endopeptidase EC.3.4.24.11. Br J Pharmacol 109(4):1024–1028

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abassi Z et al (2022) Edema formation in congestive heart failure and the underlying mechanisms. Front Cardiovasc Med 9:933215

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akiyama H et al (2001) Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition. Brain Res 902(2):277–281

Article  CAS  PubMed  Google Scholar 

AlAnazi FH et al (2023) Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena. J Diabetes 15(5):397–408

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ali NH et al (2024) Neprilysin inhibitors and risk of Alzheimer’s disease: A future perspective. J Cell Mol Med 28(2):e17993

Article  CAS  PubMed  Google Scholar 

Alvim RO et al (2015) General aspects of muscle glucose uptake. Acad Bras Cienc 87(1):351–368

Article  CAS  Google Scholar 

Arpin M et al (2011) Emerging role for ERM proteins in cell adhesion and migration. Cell Adh Migr 5(2):199–206

Article  PubMed  PubMed Central  Google Scholar 

Auer-Grumbach M et al (2016) Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies. Am J Hum Genet 99(3):607–623

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bagnato A, Natali PG (2004) Endothelin receptors as novel targets in tumor therapy. J Transl Med 2(1):16

Article  PubMed  PubMed Central  Google Scholar 

Balint L et al (2023) Clinical Potential of Adrenomedullin Signaling in the Cardiovascular System. Circ Res 132(9):1185–1202

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baraniuk JN et al (1995) Localization of neutral endopeptidase (NEP) mRNA in human bronchi. Eur Respir J 8(9):1458–1464

Article  CAS  PubMed  Google Scholar 

Bayes-Genis A, Barallat J, Richards AM (2016) A test in context: neprilysin: function, inhibition, and biomarker. J Am Coll Cardiol 68(6):639–653

Article  CAS  PubMed  Google Scholar 

Bayes-Genis A, Morant-Talamante N, Lupon J (2016) Neprilysin and natriuretic peptide regulation in heart failure. Curr Heart Fail Rep 13(4):151–157

Article  CAS  PubMed  Google Scholar 

Bekassy Z et al (2022) Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation. Nat Rev Immunol 22(7):411–428

Article  CAS  PubMed  Google Scholar 

Bellis A et al (2020) The rationale of neprilysin inhibition in prevention of myocardial ischemia-reperfusion injury during ST-elevation myocardial infarction. Cells. https://doi.org/10.3390/cells9092134

Article  PubMed  PubMed Central  Google Scholar 

Belyaev ND et al (2009) Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep 10(1):94–100

Article  CAS  PubMed  Google Scholar 

Bernardi MH et al (2021) Urinary neprilysin for early detection of acute kidney injury after cardiac surgery: A prospective observational study. Eur J Anaesthesiol 38(1):13–21

Article  CAS  PubMed  Google Scholar 

Borbely E, Scheich B, Helyes Z (2013) Neuropeptides in learning and memory. Neuropeptides 47(6):439–450

Article  CAS  PubMed  Google Scholar 

Bozkurt B et al (2023) Neprilysin Inhibitors in Heart Failure: The Science, Mechanism of Action, Clinical Studies, and Unanswered Questions. JACC Basic Transl Sci 8(1):88–105

Article  PubMed  Google Scholar 

Brecher P (1996) Angiotensin II and cardiac fibrosis. Trends Cardiovasc Med 6(6):193–198

Article  CAS  PubMed  Google Scholar 

Brignone J et al (2021) Protection of kidney function and tissue integrity by pharmacologic use of natriuretic peptides and neprilysin inhibitors. Pflugers Arch 473(4):595–610

Article  CAS  PubMed  Google Scholar 

Broccolini A et al (2008) Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle. J Neurochem 105(3):971–981

Article  CAS  PubMed  Google Scholar 

Brum WS et al (2024) Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial. JAMA Neurol 81(2):197–200

Article  PubMed  PubMed Central  Google Scholar 

Burke RM et al (2019) Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts. Circ Heart Fail 12(4):e005565

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campbell DJ (2018) Neprilysin Inhibitors and Bradykinin. Front Med (Lausanne) 5:257

Article  PubMed  PubMed Central  Google Scholar 

Campbell DJ (2003) Vasopeptidase inhibition: a double-edged sword? Hypertension 41(3):383–389

Article  CAS  PubMed  Google Scholar 

Campos CR et al (2020) Brain Shuttle Neprilysin reduces central Amyloid-beta levels. PLoS ONE 15(3):e0229850

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao X, Sudhof TC (2001) A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293(5527):115–120

Article  CAS  PubMed  Google Scholar 

Carpentier M et al (2002) Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61(10):849–856

Article  CAS  PubMed  Google Scholar 

Chadarevian JP et al (2025) Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins. Cell Stem Cell 32(6):914–934e8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen GF et al (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin 38(9):1205–1235

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen L, Yan X (2025) LncRNA NORAD sponging to miR-26b-5p represses the progression of Alzheimer’s disease in vitro by upregulating M